Hexose and pentose prodrugs of ethacrynic acid

Details Hexose and pentose prodrugs of ethacrynic acid Hexose and pentose prodrugs of ethacrynic acid

1996-02-23

1996-10-15

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514913, A61K 3170

Patent

active

055654347

ABSTRACT:
A method of reducing intraocular eye pressure by topically applying to an affected eye a small but therapeutically effective intraocular eye pressure reducing amount of a compound which is a 2-deoxyglucose or hexose or pentose derivative of ethacrynic acid.

REFERENCES:
patent: 4731381 (1988-03-01), Abraham et al.
patent: 4757089 (1988-07-01), Epstein
patent: 4855289 (1989-08-01), Wester et al.
patent: 5244922 (1993-09-01), Burzynski
patent: 5306731 (1994-04-01), Epstein
patent: 5352702 (1994-10-01), Cyrlin
patent: 5395847 (1995-03-01), Weinstock et al.
patent: 5424450 (1995-06-01), Boswell et al.
patent: 5472706 (1995-12-01), Friedman et al.
Wang et al., Arch Ophthalmol/vol. 112, Mar. 1994, pp. 390-394.
Tingey et al., Arch Ophthalmol/vol. 110, May 1992, pp. 699-702.
Johnson et al., Current Eye Research/vol. 12 No. 5 1993, 385-396.
Cynkowska et al., Abstract PDD 7145, American Association of Pharmaceutical Scientists, Nov. 1995, p. S-229.
Melamed et al., Abstract of Association Meeting, Association for Research in Vision Ophthalmology (ARVO), (1992).

Affiliated with

Also associated with

Rating

Hexose and pentose prodrugs of ethacrynic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hexose and pentose prodrugs of ethacrynic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexose and pentose prodrugs of ethacrynic acid will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246138